Last reviewed · How we verify
NCT00790166: CIA-6
Effects of nCPAP With and Without Humidification on: Inspiratory Temperature, Humidity, Saccharine Transit Time, Nasal Lavage and in Vitro Mucus Properties in Patients With Obstructive Sleep Apnea
NA trial testing CPAP + ThermoSmart™ humidity in Obstructive Sleep Apnea in 4 participants. Terminated before completion.
24 June 2009
Quick facts
| Lead sponsor | Fisher and Paykel Healthcare |
|---|---|
| Phase | NA |
| Status | Terminated |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | crossover |
| Masking | single |
| Primary purpose | treatment |
| Enrollment | 4 |
| Start date | 1 October 2008 |
| Primary completion | 24 June 2009 |
| Estimated completion | 24 June 2009 |
| Sites | 1 location across Brazil |
Drugs / interventions tested
- CPAP + ThermoSmart™ humidity
- CPAP + Conventional humidity
- CPAP + No added humidity
Conditions studied
- Obstructive Sleep Apnea — all drugs for Obstructive Sleep Apnea →
Sponsor
Fisher and Paykel Healthcare — full company profile →
Who can join
18 and older, any sex, with Obstructive Sleep Apnea. Patients with the condition only — healthy volunteers not accepted.
What's being measured
Primary outcomes are the specific endpoints the trial is designed to prove or disprove.
-
mucociliary clearance.
Time frame: pre and post cpap treatment with varying levels of humidity
Sponsor's own description
That the level of humidification delivered to patients during CPAP treatment will alter the subjects mucociliary clearance rate and related mucus properties.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT00790166
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Obstructive Sleep Apnea
Currently open trials in the same condition.
- NCT07195253 — Oro-myofunctional Characteristics and Obstructive Sleep Apnea in Infants With Down Syndrome · recruiting
- NCT07273019 — Tongue Muscular Assessment in Children With Sleep Disordered Breathing · NA · recruiting
- NCT07447011 — Glaucoma Respsosne to Lifestyle Corrections in Sleep Apnea · NA · recruiting
- NCT07397780 — RPMO2 Oximeter Accuracy During Sleep 1 Trial · active not recruiting
- NCT06698809 — Obstructive Sleep Apnea Therapeutic Intervention for REsiDual Sleepiness · NA · recruiting
Other Fisher and Paykel Healthcare trials
Trials by the same sponsor.
- NCT07484802 — Vela Generation II: Usability and Performance of a Non-Invasive Ventilation Mask. · NA · not yet recruiting
- NCT06939920 — NIV With Airway Washout for Dual Limb Ventilation: Improvement in Minute Ventilation · NA · not yet recruiting
- NCT06738589 — The Inflate Study; Defining the Soft Palate in the Upper Airway Flow Pathway · NA · not yet recruiting
- NCT06670482 — The Effect of Mask Design on Transcutaneous Carbon Dioxide in Healthy Volunteers: A Pilot Clinical Investigation · NA · completed
- NCT06060717 — Evaluation of the F&P Caramel Nasal Mask, US, 2023 · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT00790166 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Fisher and Paykel Healthcare
- Last refreshed: 25 April 2018
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT00790166.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing